Network Mapping of Molecular Biomarkers Influencing Radiation Response in Rectal Cancer
Open Access
- 1 June 2019
- journal article
- review article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 18 (2) , e210-e222
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research
- Bowel Disease Research Foundation
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Imperial College
This publication has 96 references indexed in Scilit:
- YKL-40 acts as an angiogenic factor to promote tumor angiogenesisFrontiers in Physiology, 2013
- Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiationBMC Clinical Pathology, 2012
- Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancerOncogene, 2011
- The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinomaColorectal Disease, 2011
- Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal TreatmentAnnals of Surgical Oncology, 2011
- Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapyMedical Oncology, 2011
- Gene Expression Profiles of Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor and Hypoxia-inducible Factor-1 with Special Reference to Local Responsiveness to Neoadjuvant Chemoradiotherapy and Disease Recurrence After Rectal Cancer SurgeryClinical Oncology, 2010
- Reg IV Regulates Normal Intestinal and Colorectal Cancer Cell Susceptibility to Radiation-Induced ApoptosisGastroenterology, 2010
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- HIF-1 and tumour radiosensitivityBritish Journal of Cancer, 2006